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Background
We assessed the antigen-specific CD4 and CD8 T lympho-
cyte responses elicited by a unique vaccine antigen
matched and single Clade C DNA-poxvirus-protein regi-
men in mice and determined the immunomodulatory
effect of the novel micellar formulation of a synthetic
TLR4 ligand, GLA-AF (GLA) administered either sequen-
tially or simultaneously with the MVA and protein.
Methods
Groups of 10 BALB/c mice were primed with plasmid
DNA encoding CN54 env/gag-pol-nef and then boosted
with MVA-C (env-gag-pol-nef) and CN54gp140 protein
with or without GLA-AF. The MVA and protein were
either given sequentially at 3 weekly intervals or simulta-
neously in different legs at 3 and 6 weeks. Cellular
responses were assessed at necropsy three weeks after the
final immunization. Splenocytes were harvested and ana-
lysed for antigen-specific T cell responses using peptide
pools spanning the Env and Gag proteins by intracellular
cytokine staining and CFSE labelling. Multiparametric
flow profiles were analysed using FlowJo and data sets
were organized and charted using the SPICE software.
Results
GLA adjuvanted CN54gp140 substantially influenced the
antigen-specific T lymphocyte cytokine expression pro-
files and proliferative responses in animals primed with
DNA and boosted by MVA or those immunized with
MVA alone. We observed adjuvant-induced changes in
the polyfunctional IFN-g, TNF-a and IL-2 expression
profiles of both the CD4 and CD8 T lymphocyte popula-
tions and differential responses to separate peptide pools.
Conclusion
We have shown that the GLA adjuvant alters both the
degree and the nature of the antigen-specific T lympho-
cyte responses and that these immunomodulatory
changes are critically dependent upon the timing of
application. These effects are likely due to either the
presence of systemic GLA providing a general immu-
nostimulatory environment or enhanced T cell priming
in the local draining lymph nodes. This ability to tailor
CN54gp140-specific T cell immunity is a valuable tool
to be exploited in vaccine design.
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